跳至主要内容
临床试验/NCT04258020
NCT04258020终止不适用

Exploratory Trial to Improve Postextubation Management for Patients at Risk for Extubation Failure

OhioHealth2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2020年2月11日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
OhioHealth
入组人数
6
试验地点
2
主要终点
Re-intubation Within 72 Hours

研究概览

简要总结

At the time of weaning from mechanical ventilation, patients with heart and/or lung conditions will be given oxygen support with alternating bilevel positive airway pressure (BiPAP; oxygen via face mask) and heated high flow nasal cannula oxygen (HFNC; oxygen via nasal cannula) to see if this method reduces the likelihood of re-intubation.

详细描述

It is clinically challenging to predict when patients can be successfully removed from mechanical ventilation (MV). Liberating high-risk patients such as the elderly and those with complex, chronic cardiac or pulmonary diseases from MV is particularly challenging.

Evidence from randomized trials and meta-analyses suggests that the type of postextubation supportive care provided, such as oxygen delivery via nose or mouth, may affect the risk of reintubation. However, it is unclear which of many possible postextubation management protocols results in the best patient outcomes, particularly for this subset of high-risk patients.

The purpose of this study is therefore to assess a standardized combined protocol of postextubation oxygen delivery consisting of early, alternating BiPAP with HFNC over 24 hours following extubation. BiPAP and HFNC are both currently provided to patients as standard of care, based on clinician judgement; however, the timing and nature of the methods are variable.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Documented high-risk factors of interest [congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), and/or positive fluid balance]
  • The modified rapid shallow breathing index on day of extubation must be between 58-105 breaths per minute per liter (breaths/min/L)
  • Patient must successfully complete spontaneous breathing trial and be determined eligible for extubation
  • Only primary extubations will be included

排除标准

  • Undergoing terminal extubation or placed on comfort care
  • Home ventilator use
  • Any contraindication that would preclude the postextubation protocol (e.g., facial trauma, tracheotomy, or any other reason that would preclude use of BiPAP or HFNC)

结局指标

主要结局

Re-intubation Within 72 Hours

时间窗: 72 hours following extubation

The number of patients who require re-intubation

次要结局

  • Mortality(Through hospital discharge, an average of 10.9 ± 1.91 days)
  • Re-intubation Within 1 Week(1 week following extubation)
  • 30-day Readmission(30 days following discharge)
  • Length of Stay(Through hospital discharge, an average of 10.9 ± 1.91 days)
  • Ventilator Time(Through hospital discharge, an average of 10.9 ± 1.91 days)
  • Adverse Event Rate(Through 1 week following extubation)

研究者

发起方
OhioHealth
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Postextubation Management in Patients at Risk for... | 临床试验